Inspiring Hispanic/Latinx Scientists
The Atlas of Inspiring Hispanic/Latinx Scientists is a grassroots effort developed to showcase the expertise, talents, and diversity of Hispanic and Latinx scientific faculty.
The Atlas of Inspiring Hispanic/Latinx Scientists is a grassroots effort developed to showcase the expertise, talents, and diversity of Hispanic and Latinx scientific faculty.
As we come within a stone’s throw of Nov. 5, we can’t help but wonder if and how the election outcome will impact health care…
Background: Some genomic alterations in non–small cell lung cancer (NSCLC) are known to differ according to race, sex, or age. These studies have been limited…
If clinical research were anything like fly fishing, the scientific question that EA3163 trial attempted to answer might be considered “the one that got away”:…
The FDA approved inavolisib plus palbociclib/fulvestrant for select PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer.
Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from…
Un 81,2 por ciento de los pacientes con cáncer de pulmón en estadios avanzados accede a biomarcadores en…
A new first-line treatment involving the PD-1 inhibitor nivolumab for advanced-stage classic Hodgkin lymphoma could soon make its way into clinics. To access this subscriber-only…
Research discoveries and technological innovations are continually improving cancer prevention, detection, diagnosis, and treatment.
Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of…
Wayne A. I. Frederick, a surgical oncologist and former president of Howard University, will step in as interim chief executive officer of the American Cancer…